X-PACT Immunolight (Breast Cancer, Head & Neck Cancer, Melanoma, and Sarcoma)

What is the Purpose of this Study?

If you join this study, you will:
- Be injected with the study treatment (X-PACT) five times
- Give tumor tissue
- Have physical exams, blood draws, and urine tests
- Have a heart scan (ECG)
- Have imaging scans (X-Rays, MRI and/or CT)

Please visit https://www.immunolight.com/patients to learn more about the study treatment.
What is the Condition Being Studied?
Sarcoma, Breast Cancer, Melanoma, and Head & Neck Cancer

Who Can Participate in this Study?

Adults ages 18+ who:

- Have soft tissue sarcoma, melanoma, breast cancer, or head and neck cancer

- Still have cancer after treatment with the standard therapies

- Do not have any other treatment options left

For more information about who can join this study, please contact the study team at elizabeth.sachs@duke.edu

Age Group
Participating Institutions

What is Involved?

We are doing this study to find out if an experimental drug and device system called X-PACT is a safe and effective treatment for various forms of cancer.

Study Details

Full Title
Phase 1 Study of X-PACT (X-ray Psoralen Activated Cancer Therapy) for Intra-tumoral Injection in Patients with Advanced Head and Neck Cancer, Breast Cancer, Soft Tissue Sarcoma or Melanoma
Principal Investigator
William Eward
Frank H. Bassett III, M. D. Associate Professor of Orthopaedic Surgery

Protocol Number

View on ClinicalTrials.gov